Benzinga | Oct 29, 2020 07:15AM EDT

Abiomed Q2 EPS $1.36 Beats $0.92 Estimate, Sales $209.76M Beat $198.93M Estimate

Abiomed (NASDAQ:ABMD) reported quarterly earnings of $1.36 per share which beat the analyst consensus estimate of $0.92 by 47.83 percent. This is a 32.04 percent increase over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $209.76 million which beat the analyst consensus estimate of $198.93 million by 5.45 percent. This is a 2.34 percent increase over sales of $204.97 million the same period last year.